Cerus Corp. Hits New 12-Month Low at $3.59 (CERS)
Shares of Cerus Corp. (NASDAQ:CERS) reached a new 52-week low during trading on Friday , American Banking News.com reports. The company traded as low as $3.59 and last traded at $3.66, with a volume of 371,443 shares. The stock had previously closed at $3.77.
A number of analysts have recently weighed in on CERS shares. Analysts at Cantor Fitzgerald cut their price target on shares of Cerus Corp. from $8.00 to $7.00 in a research note on Monday, May 5th. They now have a “buy” rating on the stock. Analysts at MLV & Co
cut their price target on shares of Cerus Corp. from $8.50 to $6.00 in a research note on Friday, May 2nd. They now have a “buy” rating on the stock.
The stock’s 50-day moving average is $4.07 and its 200-day moving average is $5.14. The company’s market cap is $263.9 million.
Cerus Corp. (NASDAQ:CERS) last posted its quarterly earnings results on Thursday, May 1st. The company reported ($0.12) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.12). The company had revenue of $7.86 million for the quarter, compared to the consensus estimate of $9.65 million. The company’s revenue for the quarter was down 19.2% on a year-over-year basis. Analysts expect that Cerus Corp. will post $-0.49 EPS for the current fiscal year.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.